Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

AGY Therapeutics

AGY Therapeutics has one focus: the discovery, development and commercialization of breakthrough treatments for diseases of the central nervous system. AGY has a pipeline of novel CNS therapeutic programs in the clinic and in preclinical development to meet major unmet medical needs. AGY built its pipeline using its unique, proprietary platform for functional gene discovery and mapping out specific pathways underlying central nervous system diseases. By harnessing these capabilities, AGY identified potential target proteins that can be modulated to block the progression of disease. This is paving the way for novel CNS therapeutics and future growth for AGY.


Contact Details:
270 E. Grand Avenue
South San Francisco
California
94080
United States of America
Tel:650.615.4530
Fax:650.615.4544
Email:
WWW:

www.agyinc.com/




Loading...

Recent Publications by AGY Therapeutics:

Expression and function of striatal enriched protein tyrosine phosphatase is profoundly altered in cerebral ischemia.
Striatal enriched protein tyrosine phosphatase (STEP) acts in the central...
2nd July, 2008
AGY Therapeutics Inc, South San Francisco, CA 94080, USA. Eur J Neurosci. 2008 May;27(9):2444-52.
DOI Direct Link
Npas4, a novel helix-loop-helix PAS domain protein, is regulated in response to cerebral ischemia.
Basic helix-loop-helix PAS domain proteins form a growing family of...
31st January, 2007
AGY Therapeutics, South San Francisco, California 94080, USA. Eur J Neurosci. 2006 Nov;24(10):2705-20.
DOI Direct Link
Synaptic plasticity: one STEP at a time.
Striatal enriched tyrosine phosphatase (STEP) has recently been identified...
13th October, 2006
AGY Therapeutics Inc., 270 E. Grand Avenue, South San Francisco, CA 94080, Trends Neurosci. 2006 Aug;29(8):452-8. Epub 2006 Jun 30.
DOI Direct Link
Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP).
Regulation of N-methyl-D-aspartate (NMDA) receptors is critical for the...
29th September, 2006
AGY Therapeutics Inc, 270 E. Grand Avenue, South San Francisco, CA 94080, Eur J Neurosci. 2006 Jun;23(11):2847-56.
DOI Direct Link
Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2.
Invasion of glioma cells involves the attachment of invading tumor cells...
24th June, 2006
AGY Therapeutics, Inc., 270 East Grand Avenue, South San Francisco, CA J Neurooncol. 2006 Feb;76(3):239-48.
DOI Direct Link

View more AGY Therapeutics research publications.

BioNews Results for AGY Therapeutics:

EKR Therapeutics Named Private Company of the Year By New Jersey Technology Council
Pharma Live:  Nov 23 2009 2:58AM Matching: therapeutics
Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group
PR Newswire:  Nov 23 2009 12:48AM Matching: therapeutics
Cornerstone Therapeutics Appoints General Counsel
Pharma Live:  Nov 22 2009 3:01PM Matching: therapeutics
Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of ...
PipelineReview:  Nov 22 2009 12:12AM Matching: therapeutics
Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
Freshnews.com:  Nov 21 2009 12:41AM Matching: therapeutics
Promote your company here: BioNewsCast - Press Release Distribution

View more AGY Therapeutics news.

AGY Therapeutics Patents:

US Patent No.Title
7060275 Use of protein biomolecular targets in the treatment and visualization of brain tumors
6470277 Techniques for facilitating identification of candidate genes
6521414 Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1
6586239 Purifying microglial cells by binding cell Fc receptor to immunoglobulin G Fc domain
6660483 Diagnostic marker for neurological conditions

View more AGY Therapeutics patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 504 times since April 2007, the link to the organisation's website has been followed 137 times

Recent Search Terms used to find this page: Agy Therapeutics | AGY THERAPEUTICS | agy ther | agy therapeutics | AGY Therapeutics | AGY Terapeutics | .

Search for more companies in South San Francisco

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AGY Therapeutics

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.